abnormal locomotor behavior_Chrm4<tm1Minm>/Chrm4<tm1Minm>

http://metadb.riken.jp/0001392I129X1SvJDBA2JChrm4tm1MinmChrm4tm1MinmChrm4tm1Minm

abnormal locomotor behavior_Chrm4<tm1Minm>/Chrm4<tm1Minm>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cholinergic receptor, muscarinic 4
  http://metadb.riken.jp/db/mgi_rdf/MGI:88399

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Chrm4<tm1Minm>/Chrm4<tm1Minm>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Chrm4<tm1Minm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * DBA/2J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal locomotor behavior
  http://purl.obolibrary.org/obo/MP_0001392

文献

http://purl.org/net/cito/citesAsAuthority

• Hiroshi. Karasawa, et.al., Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4., European journal of pharmacology, 2003, 468
  http://rdf.ncbi.nlm.nih.gov/pubmed/12729838